Clinical characteristics of symptomatic clostridium difficile infection in children: Conditions as infection risks and whether probiotics is effective

Pediatric Gastroenterology, Hepatology and Nutrition

Volumn 17, Issue 4, 2014, Pages 232-238

  Na, Jae Yoon ^a   Park, Jong Mo ^a   Lee, Kyung Suk ^a   Kang, Jung Oak ^a   Oh, Sung Hee ^a   Kim, Yong Joo ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Child; Clostridium difficile; Diarrhea; Probiotics

Indexed keywords

EID: 84944189457     PISSN: 22348646     EISSN: 22348840     Source Type: Journal    
DOI: 10.5223/pghn.2014.17.4.232     Document Type: Article

References (28)

1. Hall IC, O'Toole E. Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, bacillus difficilis. Am J Dis Child 1935;49:390-402.
2. Burke KE, Lamont JT. Clostridium difficile infection: a worldwide disease. Gut Liver 2014;8:1-6.
3. Rousseau C, Poilane I, De Pontual L, Maherault AC, Le Monnier A, Collignon A. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis 2012;55: 1209-15.
4. Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 2010;51:2-7.
5. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med 2008;359:1932-40.
6. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and casefatality rate, United States, 2000-2005. Emerg Infect Dis 2008;14:929-31.
7. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171:466-72.
8. Katikireddi V. UK launches inquiry into Clostridium difficile outbreak. CMAJ 2005;173:138.
9. Cohen MB. Clostridium difficile infections: emerging epidemiology and new treatments. J Pediatr Gastroenterol Nutr 2009;48(Suppl 2):S63-5.
10. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010;16:604-9.
11. MetchnikoffE. The prolongation of life: optimistic studies. London: William Heinemann, 1907:161-83.
12. Lilly DM, Stillwell RH. Probiotics: growth-promoting factors produced by microorganisms. Science 1965;147: 747-8.
13. McFarland LV, Brandmarker SA, Guandalini S. Pediatric Clostridium difficile: a phantom menace or clinical reality? J Pediatr Gastroenterol Nutr 2000;31: 220-31.
14. Bryant K, McDonald LC. Clostridium difficile infections in children. Pediatr Infect Dis J 2009;28:145-6.
15. Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008;122:1266-70.
16. Wendt JM, Cohen JA, Mu Y, Dumyati GK, Dunn JR, Holzbauer SM, et al. Clostridium difficile infection among children across diverse US geographic locations. Pediatrics 2014;133:651-8.
17. Pant C, Deshpande A, Altaf MA, Minocha A, Sferra TJ. Clostridium difficile infection in children: a comprehensive review. Curr Med Res Opin 2013;29:967-84.
18. Sandora TJ, Fung M, Flaherty K, Helsing L, Scanlon P, Potter-Bynoe G, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J 2011;30:580-4.
19. Hourigan SK, Oliva-Hemker M, Hutfless S. The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease. Dig Dis Sci 2014;59:2222-7.
20. Warrack S, Duster M, Van Hoof S, Schmitz M, Safdar N. Clostridium difficile in a children's hospital: assessment of environmental contamination. Am J Infect Control 2014;42:802-4.
21. Monaghan T, Boswell T, Mahida YR. Recent advances in Clostridium difficile-associated disease. Postgrad Med J 2009;85:152-62.
22. Khan R, Cheesbrough J. Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital. J Hosp Infect 2003;54:104-8.
23. Kim BC, Yang HR, Jeong SJ, Lee KH, Kim JE, Ko JS, et al. Clostridium difficile colitis in childhood: associated antibiotics. Korean J Pediatr Gastroenterol Nutr 2002;5:143-9.
24. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006;101:812-22.
25. Hell M, Bernhofer C, Stalzer P, Kern JM, Claassen E. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic. Benef Microbes 2013;4:39-51.
26. Goldenberg JZ, Ma SS, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 2013;5:CD006095.
27. Ooi CY, Dilley AV, Day AS. Saccharomyces boulardii in a child with recurrent Clostridium difficile. Pediatr Int 2009;51:156-8.
28. Johnston BC, Ma SS, Goldenberg JZ, Thorlund K, Vandvik PO, Loeb M, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 2012;157:878-88.